Endocrine, Metabolic & Immune Disorders Drug Targets

Pharmacological Research Progress on the Regulation of Bone Metabolism and Anti-osteoporosis by Active Ingredients of Rehmannia Glutinosa

By Tingting Huang, Xin Zhang, Langqing Yu, Weiguo Wang

ReviewInterventions

The paper

Tingting Huang, Xin Zhang, Langqing Yu, Weiguo Wang

Shandong University of Traditional Chinese Medicine

Endocrine, Metabolic & Immune Disorders Drug Targets, 23 Sep 2026

doi.org/10.2174/0118715303451188260515184911 PubMed 42786838

Biomolecules3 Oct 2026
Nuciferine reduces ovariectomy-induced bone loss in rats by activating autophagy
Pharmaceutical Biology9 Oct 2026
Honokiol promotes bone formation and fracture repair in mice
Advanced Materials2 Oct 2026
Bone-targeted exosomes delivering betaine reverse bone loss in osteoporotic rats
Advanced Science4 Oct 2026
Puerarin-loaded nanoparticles improve bone mass in mice